Yuhua Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuhua Jiang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Youxiang Li
Department of Interventional Neuroradiology, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China
4 shared publications - Fan Zhang
Xiamen Univ, Affiliated Fuzhou Hosp 2, Fuzhou, Fujian, Peoples R China
2 shared publications Hengwei Jin
Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsHuijian Ge
Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publications- Keyun Liu
Department of Interventional Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
2 shared publications Kun Hu
2 shared publications
Latest Publications
- 16 November 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (1) , 1-12
Untargeted metabolomics to detect and identify plasma metabolic signatures associated with intracranial aneurysm and its rupture
The biological basis for metabolic differences between unruptured and ruptured intracranial aneurysm (UIA and RIA) populations and their potential role in triggering IA rupture remain unclear. The aim of this study was to analyze the plasma metabolic profiles of patients with UIA and RIA using an untargeted metabolomic approach and to develop a model for early rupture classification. Plasma samples were analyzed using an ultra-high-performance liquid chromatography high-resolution tandem mass spectrometry-based platform. Least absolute shrinkage and selection operator regression and random forest machine learning methods were employed for metabolite feature selection and predictive model construction. Among 49 differential plasma metabolites identified, 31 were increased and 18 were decreased in the plasma of RIA patients. Five key metabolites—canrenone, piperine, 1-methyladenosine, betaine, and trigonelline—were identified as having strong potential to discriminate between UIA and RIA patients. This combination of metabolites demonstrated high diagnostic accuracy, with an area under the curve exceeding 0.95 in both the training and validation datasets. Our finding highlights the significance of plasma metabolites as potential biomarkers for early detection of IA rupture risk, offering new insights for clinical practice and future research on IA management.
- 16 November 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (1) , 1-12
Untargeted metabolomics to detect and identify plasma metabolic signatures associated with intracranial aneurysm and its rupture
The biological basis for metabolic differences between unruptured and ruptured intracranial aneurysm (UIA and RIA) populations and their potential role in triggering IA rupture remain unclear. The aim of this study was to analyze the plasma metabolic profiles of patients with UIA and RIA using an untargeted metabolomic approach and to develop a model for early rupture classification. Plasma samples were analyzed using an ultra-high-performance liquid chromatography high-resolution tandem mass spectrometry-based platform. Least absolute shrinkage and selection operator regression and random forest machine learning methods were employed for metabolite feature selection and predictive model construction. Among 49 differential plasma metabolites identified, 31 were increased and 18 were decreased in the plasma of RIA patients. Five key metabolites—canrenone, piperine, 1-methyladenosine, betaine, and trigonelline—were identified as having strong potential to discriminate between UIA and RIA patients. This combination of metabolites demonstrated high diagnostic accuracy, with an area under the curve exceeding 0.95 in both the training and validation datasets. Our finding highlights the significance of plasma metabolites as potential biomarkers for early detection of IA rupture risk, offering new insights for clinical practice and future research on IA management.
- Open Access
- 28 January 2021
- Published by Hindawi Limited in Applied Bionics and Biomechanics
- Vol. 2021, 1-8
Animal Experiment of a Novel Neurointerventional Surgical Robotic System with Master-Slave Mode
In order to inspect and improve the system performance of the neuro-interventional surgical robot and its effectiveness and safety in clinical applications, we conducted ten animal experiments using this robotic system. Cerebral angiography was performed on ten experimental animals, and various mechanical performance indicators, operating time, X-ray radiation dosage to the experimental animals and the experimenter, and arterial damage in the experimental animals were recorded when the robotic system completed cerebral angiography. The results show that the robotic system can successfully complete the cerebral angiography surgery, and the mechanical performance is up to standard. The operating time is almost the same as the physician’s operating time. And the mean X-ray radiation dosage received by the experimental animals and experimenter was 0.893 Gy and 0.0859 mSv, respectively. There were no complications associated with damage to the vascular endothelium. The robotic system can basically complete the relevant assessment indicators, and its system performance, effectiveness, and safety in clinical applications meet the standards, basically meeting the requirements of clinical applications of neurointerventional surgery.
- 28 January 2021
- Published by Hindawi Limited in Applied Bionics and Biomechanics
- Vol. 2021, 1-8
Open AccessAnimal Experiment of a Novel Neurointerventional Surgical Robotic System with Master-Slave Mode
In order to inspect and improve the system performance of the neuro-interventional surgical robot and its effectiveness and safety in clinical applications, we conducted ten animal experiments using this robotic system. Cerebral angiography was performed on ten experimental animals, and various mechanical performance indicators, operating time, X-ray radiation dosage to the experimental animals and the experimenter, and arterial damage in the experimental animals were recorded when the robotic system completed cerebral angiography. The results show that the robotic system can successfully complete the cerebral angiography surgery, and the mechanical performance is up to standard. The operating time is almost the same as the physician’s operating time. And the mean X-ray radiation dosage received by the experimental animals and experimenter was 0.893 Gy and 0.0859 mSv, respectively. There were no complications associated with damage to the vascular endothelium. The robotic system can basically complete the relevant assessment indicators, and its system performance, effectiveness, and safety in clinical applications meet the standards, basically meeting the requirements of clinical applications of neurointerventional surgery.
- 19 June 2019
- Published by Springer Nature in European Radiology
- Vol. 30 (1) , 301-307
Wall enhancement of intracranial saccular and fusiform aneurysms may differ in intensity and extension: a pilot study using 7-T high-resolution black-blood MRI
To evaluate and compare wall enhancement patterns in saccular and fusiform intracranial aneurysms using high-resolution black-blood MRI at 7 T.
- 19 June 2019
- Published by Springer Nature in European Radiology
- Vol. 30 (1) , 301-307
Wall enhancement of intracranial saccular and fusiform aneurysms may differ in intensity and extension: a pilot study using 7-T high-resolution black-blood MRI
To evaluate and compare wall enhancement patterns in saccular and fusiform intracranial aneurysms using high-resolution black-blood MRI at 7 T.
- Open Access
- 21 February 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (3) , 490-496
Complementary Roles of Dynamic Contrast-Enhanced MR Imaging and Postcontrast Vessel Wall Imaging in Detecting High-Risk Intracranial Aneurysms
BACKGROUND AND PURPOSE: Individual assessment of the absolute risk of intracranial aneurysm rupture remains challenging. Emerging imaging techniques such as dynamic contrast-enhanced MR imaging and postcontrast vessel wall MR imaging may improve risk estimation by providing new information on aneurysm wall properties. The purpose of this study was to investigate the relationship between aneurysm wall permeability on dynamic contrast-enhanced MR imaging and aneurysm wall enhancement on postcontrast vessel wall MR imaging in unruptured intracranial aneurysms. MATERIALS AND METHODS: Patients with unruptured saccular intracranial aneurysms were imaged with vessel wall MR imaging before and after gadolinium contrast administration. Dynamic contrast-enhanced MR imaging was performed coincident with contrast injection using 3D T1-weighted spoiled gradient-echo imaging. The transfer constant (Ktrans) was measured adjacent to intracranial aneurysm and adjacent to the normal intracranial artery. RESULTS: Twenty-nine subjects were analyzed (mean age, 53.9 ± 13.5 years; 24% men; PHASES score: median, 8; interquartile range, 4.75–10). Ktrans was higher in intracranial aneurysms compared with the normal intracranial artery (median, 0.0110; interquartile range, 0.0060–0.0390 versus median, 0.0032; interquartile range, 0.0018–0.0048 min−1; P < .001), which correlated with intracranial aneurysm size (Spearman ρ = 0.54, P = .002) and PHASES score (ρ = 0.40, P = .30). Aneurysm wall enhancement, detected in 19 (66%) aneurysms, was associated with intracranial aneurysm size and the PHASES score but not significantly with Ktrans (P = .30). Aneurysms of 2 of the 9 patients undergoing conservative treatment ruptured during 1-year follow-up. Both ruptured aneurysms had increased Ktrans, whereas only 1 had aneurysm wall enhancement at baseline. CONCLUSIONS: Dynamic contrast-enhanced MR imaging showed increased Ktrans adjacent to intracranial aneurysms, which was independent of aneurysm wall enhancement on postcontrast vessel wall MR imaging. Increased aneurysm wall permeability on dynamic contrast-enhanced MR imaging provides new information that may be useful in intracranial aneurysm risk assessment.
- 21 February 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (3) , 490-496
Open AccessComplementary Roles of Dynamic Contrast-Enhanced MR Imaging and Postcontrast Vessel Wall Imaging in Detecting High-Risk Intracranial Aneurysms
BACKGROUND AND PURPOSE: Individual assessment of the absolute risk of intracranial aneurysm rupture remains challenging. Emerging imaging techniques such as dynamic contrast-enhanced MR imaging and postcontrast vessel wall MR imaging may improve risk estimation by providing new information on aneurysm wall properties. The purpose of this study was to investigate the relationship between aneurysm wall permeability on dynamic contrast-enhanced MR imaging and aneurysm wall enhancement on postcontrast vessel wall MR imaging in unruptured intracranial aneurysms. MATERIALS AND METHODS: Patients with unruptured saccular intracranial aneurysms were imaged with vessel wall MR imaging before and after gadolinium contrast administration. Dynamic contrast-enhanced MR imaging was performed coincident with contrast injection using 3D T1-weighted spoiled gradient-echo imaging. The transfer constant (Ktrans) was measured adjacent to intracranial aneurysm and adjacent to the normal intracranial artery. RESULTS: Twenty-nine subjects were analyzed (mean age, 53.9 ± 13.5 years; 24% men; PHASES score: median, 8; interquartile range, 4.75–10). Ktrans was higher in intracranial aneurysms compared with the normal intracranial artery (median, 0.0110; interquartile range, 0.0060–0.0390 versus median, 0.0032; interquartile range, 0.0018–0.0048 min−1; P < .001), which correlated with intracranial aneurysm size (Spearman ρ = 0.54, P = .002) and PHASES score (ρ = 0.40, P = .30). Aneurysm wall enhancement, detected in 19 (66%) aneurysms, was associated with intracranial aneurysm size and the PHASES score but not significantly with Ktrans (P = .30). Aneurysms of 2 of the 9 patients undergoing conservative treatment ruptured during 1-year follow-up. Both ruptured aneurysms had increased Ktrans, whereas only 1 had aneurysm wall enhancement at baseline. CONCLUSIONS: Dynamic contrast-enhanced MR imaging showed increased Ktrans adjacent to intracranial aneurysms, which was independent of aneurysm wall enhancement on postcontrast vessel wall MR imaging. Increased aneurysm wall permeability on dynamic contrast-enhanced MR imaging provides new information that may be useful in intracranial aneurysm risk assessment.
- 27 October 2018
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 39 (5) , 653-664
Surgeons’ Operation Skill-Based Control Strategy and Preliminary Evaluation for a Vascular Interventional Surgical Robot
- 27 October 2018
- Published by Springer Nature in Journal of Medical and Biological Engineering
- Vol. 39 (5) , 653-664
Surgeons’ Operation Skill-Based Control Strategy and Preliminary Evaluation for a Vascular Interventional Surgical Robot
- Open Access
- 16 April 2018
- Published by Wiley in Applied Bionics and Biomechanics
- Vol. 2018, 1-10
Initial Clinical Trial of Robot of Endovascular Treatment with Force Feedback and Cooperating of Catheter and Guidewire
To evaluate the feasibility and safety of the robot of endovascular treatment (RobEnt) in clinical practice, we carried out a cerebral angiography using this robot system. We evaluated the performance of application of the robot system to clinical practice through using this robotic system to perform the digital subtraction angiography for a patient who was suspected of suffering intracranial aneurysm. At the same time, through comparing the postoperative head nuclear magnetic and blood routine with the preoperative examination, we evaluated the safety of application of the robot system to clinical practice. We performed the robot system to complete the bilateral carotid artery and bilateral vertebral arteriography. The results indicate that there was no obvious abnormality in the patient’s cerebral artery. No obvious abnormality was observed in the examination of patients’ check-up, head nuclear magnetism, and blood routine after the digital subtraction angiography. From this clinical trial, it can be observed that the robot system can perform the operation of cerebral angiography. The robot system can basically complete the related observation indexes, and its accuracy, effectiveness, stability, and safety basically meet the requirements of clinical application in neurointerventional surgery.
- 16 April 2018
- Published by Wiley in Applied Bionics and Biomechanics
- Vol. 2018, 1-10
Open AccessInitial Clinical Trial of Robot of Endovascular Treatment with Force Feedback and Cooperating of Catheter and Guidewire
To evaluate the feasibility and safety of the robot of endovascular treatment (RobEnt) in clinical practice, we carried out a cerebral angiography using this robot system. We evaluated the performance of application of the robot system to clinical practice through using this robotic system to perform the digital subtraction angiography for a patient who was suspected of suffering intracranial aneurysm. At the same time, through comparing the postoperative head nuclear magnetic and blood routine with the preoperative examination, we evaluated the safety of application of the robot system to clinical practice. We performed the robot system to complete the bilateral carotid artery and bilateral vertebral arteriography. The results indicate that there was no obvious abnormality in the patient’s cerebral artery. No obvious abnormality was observed in the examination of patients’ check-up, head nuclear magnetism, and blood routine after the digital subtraction angiography. From this clinical trial, it can be observed that the robot system can perform the operation of cerebral angiography. The robot system can basically complete the related observation indexes, and its accuracy, effectiveness, stability, and safety basically meet the requirements of clinical application in neurointerventional surgery.
- 30 September 2017
- Published by SAGE Publications in Translational Neuroscience and Clinics
- Vol. 3 (3) , 176-184
Advances in research of intracranial vascular stent
- 30 September 2017
- Published by SAGE Publications in Translational Neuroscience and Clinics
- Vol. 3 (3) , 176-184
Advances in research of intracranial vascular stent
- 1 September 2017
- Published by SAGE Publications in Translational Neuroscience and Clinics
- Vol. 3 (3) , 176-184
Advances in Research of Intracranial Vascular Stent
In recent years, China's population has shown an obvious aging trend. This trend has been accompanied by an increased incidence of cardiovascular disease and death. Intracranial stenting has become an important treatment modality for intracranial vascular disease because it is effective, safe, and widely approved. In this paper, we review the literature concerning the classification, structure, preparation, and performance of intracranial stents. We also summarize problems and future prospects in the context of intracranial stents. This paper will serve as a reference for the future research and development of intracranial stents.
- 1 September 2017
- Published by SAGE Publications in Translational Neuroscience and Clinics
- Vol. 3 (3) , 176-184
Advances in Research of Intracranial Vascular Stent
In recent years, China's population has shown an obvious aging trend. This trend has been accompanied by an increased incidence of cardiovascular disease and death. Intracranial stenting has become an important treatment modality for intracranial vascular disease because it is effective, safe, and widely approved. In this paper, we review the literature concerning the classification, structure, preparation, and performance of intracranial stents. We also summarize problems and future prospects in the context of intracranial stents. This paper will serve as a reference for the future research and development of intracranial stents.